The GPCR superfamily is a major therapeutic target whose functioning regulates several physiological processes such as vision, smell, taste, cardiovascular, neurological, and reproductive mechanisms, and A2AR in particular has been recognized as a drug target for the treatment of many diseases, including cancer, Parkinson’s and Alzheimer’s disease46,47. The gene discussed is ADORA2A; the disease is Parkinson disease.